Metastatic colorectal cancer is an incurable disease treated in a palliative setting by chemotherapy or chemotherapy plus the anti-VEGF antibody bevacizumab as a tumor angiogenesis modifying agent. This evidence concerns the gene VEGFA and neoplasm.